¿¬¼ö°­ÁÂ
2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-03-08

2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-03-08
±³À°ÀÏÀÚ : 2024-03-08
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  

À̸ÞÀÏ : office@thyroid.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í " 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 13:00~13:20 Oncocytic tumor: Radiologic perspective ÇѼö¿¬(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 13:20~13:40 Pathologic perspectives ½ÅÇüÂù(°è¸íÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 13:40~14:00 Clinical perspectives ±è¼ö¿µ(¾ÆÁÖÀÇ´ë ¿Ü°ú)

Åä·Ð 03¿ù 08ÀÏ 201È£ 14:00~14:10 Discussion ()

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 14:10~14:30 Appropriate RAI treatment strategies for low-intermediate risk DTC ±èÈñ°æ(Àü³²ÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 14:30~14:50 Risk and benefits of high-dose RAI treatment for advanced DTC ¿À¼Ò¿ø(¼­¿ïÀÇ´ë ÇÙÀÇÇаú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 14:50~15:10 Defining RAI refractory thyroid cancer & when to start TKI treatment ±è¿ø±¸(¿ï»êÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 08ÀÏ 201È£ 15:10~15:20 Discussion ()

ÈÞ½Ä 03¿ù 08ÀÏ 201È£ 15:20~15:40 Coffee Break ()

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 15:40~16:20 ±×·¹À̺꽺º´ÀÇ Ä¡·á½Ã Ç×°©»ó¼±Á¦ »ç¿ë ¼Û¿µ±â(¶¯Å¥¼­¿ïÀÇ¿ø ³»°ú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 16:20~16:40 Early Rehabilitation after Thyroid Surgery ¹ÚÁø¿µ(¿¬¼¼ÀÇ´ë ÀçÈ°ÀÇÇаú)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 16:40~17:00 Psychosocial Support for Thyroid Cancer Survivors Á¶ÁÖÈñ(¼º±Õ°ü´ëÇб³ »ï¼ºÀ¶ÇÕÀÇ°úÇпø)

±³À°½Ã°£ 03¿ù 08ÀÏ 201È£ 17:00~17:20 Nutrition Care after Thyroid Cancer Surgery °­ÀºÈñ(¼­¿ï¾Æ»êº´¿ø ¿µ¾çÆÀ)

Åä·Ð 03¿ù 08ÀÏ 201È£ 17:20~17:30 Discussion ()

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:00~13:10 [±¸¿¬¹ßÇ¥] Long-Term Clinical Outcomes and Prognostic Factors of Medullary Thyroid Carcinoma Over 30 Years "¿À¹®¿µ (¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:10~13:20 [±¸¿¬¹ßÇ¥] A Protein Tumor Marker in Fine Needle Aspiration Washout Fluid: Insights from a Dual Cohort Analysis of Thyroid Cancer Patients "ÀÌÁ¤¹Î (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:20~13:30 [±¸¿¬¹ßÇ¥] Endotrophin promotes tumor growth by supporting immune-suppressive hypoxic microenvironments in anaplastic thyroid cancer "±èÀ¯Çü (¼­¿ï´ëÇб³º´¿ø ³»ºÐºñ³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:30~13:40 [±¸¿¬¹ßÇ¥] Performance enhancement of a heart rate-based thyrotoxicosis prediction machine learning-assisted system through reference to multiple TFT Results "½Å±Ôº¸ (ÁÖ½Äȸ»ç ŸÀ̷νºÄÚÇÁ)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:40~13:50 [±¸¿¬¹ßÇ¥] In Graves' disease surgery, goiter size may be more important than the patient's preoperative euthyroid status "À¯ÁöÇö (»ï¼º¼­¿ïº´¿ø ³»ºÐºñ´ë»ç³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 13:50~14:00 [±¸¿¬¹ßÇ¥] Highly Targeted TERT Mutation Detection in Thyroid Cancer Through Digital Droplet PCR "ÀÌÁ¤¹Î (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 14:10~14:20 [±¸¿¬¹ßÇ¥] Selenium Efficacy in Mild-to-Moderate Graves¡¯ Ophthalmopathy within Selenium-Sufficient Regions (SeGOSS Trial): A Phase III, Multicenter, Open-Label, Randomized, Controlled Intervention Study "ÀåÁø¼± (¼­¿ï´ëÇб³º´¿ø ³»ºÐºñ³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 14:20~14:30 [±¸¿¬¹ßÇ¥] Prognosis of patients with brain metastases of differentiated thyroid carcinoma "±èä¾Æ (¼­¿ï¾Æ»êº´¿ø ³»ºÐºñ³»°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 14:30~14:40 [±¸¿¬¹ßÇ¥] Utilizing IgG4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis "Á¤Âù±Ç (¼­¿ï¼º¸ðº´¿ø º´¸®°ú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 14:40~14:50 [±¸¿¬¹ßÇ¥] Validation of Glandy CAS Software in the Assessment of Thyroid Eye Disease Activity: A Confirmatory Clinical Trial "±èÁ¾Âù (ÁÖ½Äȸ»ç ŸÀ̷νºÄÚÇÁ)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 14:50~15:00 [±¸¿¬¹ßÇ¥] Metastatic lymph node with ultrasonographic punctate echogenic foci (PEF) harbors PEF in primary thyroid cancer "¹Ú¼ö¸° (°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ ÇÙÀÇÇаú)"

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 15:00~15:10 [±¸¿¬¹ßÇ¥] 10-year follow-up of radiofrequency ablation of benign thyroid nodule: perspective on technical outcome "½ÅÀçÈ£ (°í·Á´ëÇб³ ¾È¾Ïº´¿ø ¿µ»óÀÇÇаú)"

ÈÞ½Ä 03¿ù 08ÀÏ 204,5È£ 15:20~15:40 Coffee Break ()

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 15:40~16:20 Far advanced thyroid cancer - How far can we try? ÀåÇ×¼®(¿¬¼¼ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 16:20~16:40 ÀÇÇÐ ¿¬±¸¿¡¼­ÀÇ Generative AI¿Í Large Language Model: ÇöȲ°ú Àü¸Á Á¤±Ôȯ(¼º±Õ°ü´ëÇб³ »ï¼ºÀ¶ÇÕÀÇ°úÇпø)

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 16:40~17:00 °©»ó¼± ÀÇÇבּ¸¿¡¼­ÀÇ Large Language ModelÀÇ Àû¿ë »ç·Ê ¹Ú±â¼º(Àü³²ÀÇ´ë ÇÙÀÇÇаú)

±³À°½Ã°£ 03¿ù 08ÀÏ 204,5È£ 17:00~17:20 Prompt Engineering: ÀÇÇÐ³í¹® ÀÛ¼º¿¡¼­ÀÇ ChatGPT »ç¿ë Knowhow À̷οî(ÀÎÇÏÀÇ´ë ¿µ»óÀÇÇаú)

Åä·Ð 03¿ù 08ÀÏ 204,5È£ 17:20~17:30 Discussion ()

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,163 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ±³À°ÁÖÁ¦ : SICEM 2024(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ ´ã´çÀÚ : ¹Ú¼öºó ¿¬¶ôó : 02-2038-0

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,062 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,211 , ´ñ±Û¼ö : 0

[±¤ÁÖ] ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁß ÄÁº¥¼Ç ¼¾ÅÍ ÄÁº£¼Ç Ȧ ¿Ü 8°÷ ±³À°ÁÖÁ¦ : ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd dayÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 906 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Surgeon : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : °­³²¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Sur

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,126 , ´ñ±Û¼ö : 0